Linking the Genetics of Type 2 Diabetes With Low Birth Weight
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Diabetes develops if pancreatic β-cells fail to provide sufficient amounts of insulin at a given degree of insulin resistance. In type 1 diabetes, the extent of β-cell loss at the time of disease onset has been estimated to be ∼60–70% (1,2), while studies in patients with type 2 diabetes and individuals with impaired fasting glucose have reported β-cell deficits of ∼65 and ∼50%, respectively (3). However, while impaired islet cell mass and function seem to determine the development of diabetes to a large extent, individual risk undoubtedly also depends on other parameters, such as obesity and insulin resistance (4). Over the years, increasing evidence has accumulated that shows that, in addition to these established risk factors, low birth weight is also associated with a greater risk of developing type 2 diabetes later in life (5,6). The causes underlying this association have been debated, and fetal malnutrition has been proposed as a potential mechanism (7,8). Freathy et al. (9), as reported in this issue of Diabetes , have now tested the alternative hypothesis (the fetal insulin hypothesis) that genetic variants predisposing to type 2 diabetes might also reduce birth weight by altering intrauterine insulin secretion or action. Using fetal DNA from 7,986 mothers and …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683 · cited 1×
“Consistent with such reasoning, autopsy studies in 46 children aged between 2 weeks and 21 years have revealed a more than fivefold variation in pancreatic -cell area between children of similar age (19).”
ResultSelf-citationIntrauterine Growth Retardation Leads to the Development of Type 2 Diabetes in the Rat
Simmons, R. A., Templeton, L. J., & Gertz, S. J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2279 · Cited by 638 · cited 1×
“The causes underlying this association have been debated, and fetal malnutrition has been proposed as a potential mechanism (7,8).”
BackgroundEthnicity, Obesity, and Risk of Type 2 Diabetes in Women
Shai, I., Jiang, R., Manson, J. E., Stampfer, M. J., Willett, W. C., Colditz, G. A., & Hu, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-0057 · Cited by 479
In utero undernutrition impairs rat beta-cell development
Garofano, A., Czernichow, P., & Bréant, B. (1997) · Diabetologia · doi:10.1007/s001250050812 · Cited by 320
Beta cell mass in diabetes: a realistic therapeutic target?
Meier, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-0936-9 · Cited by 155 · cited 1×
“Indeed, -cell mass has been increasingly recognized as a central cause of type 2 diabetes over the years (10).”
BackgroundSelf-citation
Cited by
Ding, G.-L., Wang, F.-F., Shu, J., Tian, S., Jiang, Y., Zhang, D., Wang, N., Luo, Q., Zhang, Y., Jin, F., et al. (2012) · Diabetes · doi:10.2337/db11-1314 · Cited by 292
Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
Wysham, C., & Shubrook, J. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1771047 · Cited by 193
Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes Trial
Rowan, J. A., Gao, W., Hague, W. M., & McIntyre, H. D. (2010) · Diabetes Care · doi:10.2337/dc09-1407 · Cited by 96
Bhopal, R. S. (2013) · Diabetic Medicine · doi:10.1111/dme.12016 · Cited by 77
Cheong, J. N., Cuffe, J. S. M., Jefferies, A. J., Anevska, K., Moritz, K. M., & Wlodek, M. E. (2016) · Endocrinology · doi:10.1210/en.2016-1335 · Cited by 28
Metadata
- Authors
- Meier, J. J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 58
- Issue
- 6
- Pages
- 1255-1256
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111593782
- Cited by
- 33
- References
- 5
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.